Key result
Treatment with eight cycles of R-CHOP chemotherapy and a resynchronisation device improved ejection fraction to 45%-50% in a 48-year-old man with cardiac lymphoma presenting as complete heart block.
Population
A 48-year-old man presenting with presyncope and complete heart block
Design
Case report
Authors
Loading...
May indicate reversibility of severe LV dysfunction in cardiac lymphoma with chemotherapy plus resynchronization; hypothesis-generating, needs prospective validation.
Case Report (n=1)
Complete heart block can be an early presentation of cardiac lymphoma, and subsequent chemotherapy-induced cardiomyopathy may respond well to cardiac resynchronization therapy.
Morgan et al. (2021) conducted a case report in Cardiac lymphoma (n=1). R-CHOP chemotherapy and resynchronisation device was evaluated on Clinical and radiological improvement, ejection fraction. Treatment with eight cycles of R-CHOP chemotherapy and a resynchronisation device improved ejection fraction to 45%-50% in a 48-year-old man with cardiac lymphoma presenting as complete heart block.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: